Correlation Between Summit Therapeutics and Blade Air
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Blade Air at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Blade Air into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Blade Air Mobility, you can compare the effects of market volatilities on Summit Therapeutics and Blade Air and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Blade Air. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Blade Air.
Diversification Opportunities for Summit Therapeutics and Blade Air
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Summit and Blade is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Blade Air Mobility in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blade Air Mobility and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Blade Air. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blade Air Mobility has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Blade Air go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Blade Air
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.08 times more return on investment than Blade Air. However, Summit Therapeutics is 1.08 times more volatile than Blade Air Mobility. It trades about 0.22 of its potential returns per unit of risk. Blade Air Mobility is currently generating about -0.05 per unit of risk. If you would invest 1,928 in Summit Therapeutics PLC on October 27, 2024 and sell it today you would earn a total of 448.00 from holding Summit Therapeutics PLC or generate 23.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Summit Therapeutics PLC vs. Blade Air Mobility
Performance |
Timeline |
Summit Therapeutics PLC |
Blade Air Mobility |
Summit Therapeutics and Blade Air Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Summit Therapeutics and Blade Air
The main advantage of trading using opposite Summit Therapeutics and Blade Air positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Blade Air can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blade Air will offset losses from the drop in Blade Air's long position.Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |